At the time of writing, Atossa Therapeutics Inc [ATOS] stock is trading at $1.52, up 0.66%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ATOS shares have gain 7.80% over the last week, with a monthly amount glided 10.95%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Atossa Therapeutics Inc [NASDAQ: ATOS] stock has seen the most recent analyst activity on January 26, 2018, when Maxim Group initiated its Buy rating and assigned the stock a price target of $2.
For the past year, the stock price of Atossa Therapeutics Inc fluctuated between $0.62 and $2.31. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Atossa Therapeutics Inc [NASDAQ: ATOS] shares were valued at $1.52 at the most recent close of the market. An investor can expect a potential return of 228.95% based on the average ATOS price forecast.
Analyzing the ATOS fundamentals
Gross Profit Margin for this corporation currently stands at -0.44% with Operating Profit Margin at -1698.44%, Pretax Profit Margin comes in at -1439.44%, and Net Profit Margin reading is -1439.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.29 and Total Capital is -0.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4800 points at the first support level, and at 1.4400 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5700, and for the 2nd resistance point, it is at 1.6200.
Ratios To Look Out For
It is important to note that Atossa Therapeutics Inc [NASDAQ:ATOS] has a current ratio of 14.35. As well, the Quick Ratio is 14.35, while the Cash Ratio is 13.98.
Transactions by insiders
Recent insider trading involved Finn Jonathan, Director, that happened on Apr 10 ’24 when 25000.0 shares were purchased. Former EVP, CFO, & Director, WEAVER GREGORY L completed a deal on Nov 15 ’23 to sell 50000.0 shares.
